9 90 2015 001
2 résultats affichés
-
Cipla Global Ltd.: Generics versus Drug Discovery
8,00 $ – 50,00 $CASE STUDY. Thanks to India’s process patent regime (1970–2005), Dr. Yusuf Hamied, the company’s chairman, managed to catapult the company to its position as a leading generics manufacturer.
-
Raven’s Sun Enterprise Ltd.
8,00 $ – 50,00 $CASE STUDY. Raven’s Sun Enterprise Ltd. is a small oilfield and construction site delivery business operated by firefighter Mike LaPlante on his days off. Mike is the firm’s only driver, so scheduling his time profitably is the critical success factor.
2 résultats affichés